drugset / Trial / NCT00293540

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

NCT00293540

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.

Timeline

Start
2006-02
Primary completion
2014-02
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tamoxifen Small molecule 20 mg Oral

Indications